Cybin Inc (CYBN) Return on Equity ROE from the first quarter 2026 to first quarter 2025 and annually, average high and low, overall ranking from Jun 30 2026 to 0 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Cybin Inc   (NYSEAMER: CYBN)

Cybin Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Cybin Inc in the first quarter 2026?
Cybin Inc recorded a cumulative net loss of $-193 million during 12 months ending in the first quarter 2026, resulting in a negative return on equity (ROE) of -93.03%.

Within the Major Pharmaceutical Preparations industry 182 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the fourth quarter 2025 from to 3397.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2026)
I. Quarter		 (Mar 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter
Y / Y Equity Change 46.75 % -18.75 % 527.03 % -18.75 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -193 -166 -139 -148 -134
Return On Equity (TTM) -93.03 % -88.47 % -70.26 % -97.48 % -82.67 %
CYBN's Total Ranking # 3397 # # # #
Equity (TTM) in Millions 242 182 224 182 165
Seq. Equity Change 33.24 % -18.75 % 23.07 % 10.14 % -26.23 %
Seq. Net Income Change - - - - -

Back to CYBN Management Effectiveness >> CYBN's 5 Years Annual ROE >> Compare CYBN ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 183
Sector # 432
Overall # 3397

Return On Equity Statistics
High Average Low
-26.86 %
-58.97 %
-100.73 %
(Mar 31 2024)   (Mar 31 2023)





CYBN Annual Return On Equity (Mar 31 2025)
2025		 (Mar 31 2024)
2024		 (Mar 31 2023)
2023		 (Mar 31 2021)
2022
Total Equity in Millions 165 216 36 61 0
Y / Y Equity Change -23.49 % 504.56 % -41.55 % - -
Net Income in Millions -81 -58 -36 -54 0
Y / Y Net Income Change - - - - -
Return On Equity -49.33 % -26.86 % -100.73 % -88.45 % -

Back to CYBN Management Effectiveness >> CYBN's 5 Years Annual ROE >> Compare CYBN ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
CYBN's' Return on Equity at Yahoo Finance
CYBN's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for CYBN's Competitors
Subscribers only: Roe for Cybin Inc 's Suppliers
Subscribers only: Return On Equity for CYBN's Customers




Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector ROE

Date modified: 2026-10-08T16:46:10+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.